Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection
Neoadjuvant SBRT with IOeRT during pancreatic cancer resection is feasible, achieves high rates of negative margins, and provides promising local control. Distant progression remains the dominant mode of failure.
Authors
- Gianella Cornejo
- Yair Hillman
- Antoni Skripai (ORCID: https://orcid.org/0009-0009-8581-3142)
- Gideon Zamir (ORCID: https://orcid.org/0000-0003-3133-863X)
- Mark Temper
- Alon J. Pikarsky (ORCID: https://orcid.org/0000-0002-7853-6310)
- Abed Khalaileh (ORCID: https://orcid.org/0000-0002-4878-8189)
- Liat Appelbaum
- Popovtzer Aron
- Philip Blumenfeld (ORCID: https://orcid.org/0000-0003-4672-6862)
- Ayala Hubert
- Marc Wygoda
- J. D. Feldman
- Ashraf Imam
Institutions
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1007/s00432-025-06397-2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00